The hydroxylation of omeprazole correlates with S-mephenytoin metabolism

A population study

John D. Balian, Nadia Sukhova, James W. Harris, Jan Hewett, Linda Pickle, Joyce A. Goldstein, Raymond L. Woosley, David A. Flockhart

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

We compared omeprazole and mephenytoin as probes for the CYP2C19 metabolic polymorphism. Single oral doses of omeprazole (20 mg) or mephenytoin (100 mg) were administered at least 1 week apart to 167 healthy volunteers. Mephenytoin metabolism was measured using the amount of 4′-hydroxymephenytoin and the S R ratio of mephenytoin in an 8-hour urine collection. Omeprazole hydroxylation was measured using the ratio of omeprazole to 5′-hydroxyomeprazole in serum 2 hours after dosing. All three methods separated poor- or extensive-metabolizer phenotypes with complete concordance. Omeprazole hydroxylation correlated with the S R ratio of mephenytoin in extensive metabolizers (r2 = 0.681; p <0.001). Genotyping tests showed that six poor metabolizers of omeprazole were homozygous for a single base pair mutation in exon 5 of CYP2C19. These results support the hypothesis that omeprazole 5′-hydroxylation cosegregates with the CYP2C19 metabolic polymorphism.

Original languageEnglish (US)
Pages (from-to)662-669
Number of pages8
JournalClinical Pharmacology and Therapeutics
Volume57
Issue number6
StatePublished - Jun 1995
Externally publishedYes

Fingerprint

Mephenytoin
Omeprazole
Hydroxylation
Population
Urine Specimen Collection
Base Pairing
Exons
Healthy Volunteers
Phenotype
Mutation

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Balian, J. D., Sukhova, N., Harris, J. W., Hewett, J., Pickle, L., Goldstein, J. A., ... Flockhart, D. A. (1995). The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: A population study. Clinical Pharmacology and Therapeutics, 57(6), 662-669.

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism : A population study. / Balian, John D.; Sukhova, Nadia; Harris, James W.; Hewett, Jan; Pickle, Linda; Goldstein, Joyce A.; Woosley, Raymond L.; Flockhart, David A.

In: Clinical Pharmacology and Therapeutics, Vol. 57, No. 6, 06.1995, p. 662-669.

Research output: Contribution to journalArticle

Balian, JD, Sukhova, N, Harris, JW, Hewett, J, Pickle, L, Goldstein, JA, Woosley, RL & Flockhart, DA 1995, 'The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: A population study', Clinical Pharmacology and Therapeutics, vol. 57, no. 6, pp. 662-669.
Balian JD, Sukhova N, Harris JW, Hewett J, Pickle L, Goldstein JA et al. The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: A population study. Clinical Pharmacology and Therapeutics. 1995 Jun;57(6):662-669.
Balian, John D. ; Sukhova, Nadia ; Harris, James W. ; Hewett, Jan ; Pickle, Linda ; Goldstein, Joyce A. ; Woosley, Raymond L. ; Flockhart, David A. / The hydroxylation of omeprazole correlates with S-mephenytoin metabolism : A population study. In: Clinical Pharmacology and Therapeutics. 1995 ; Vol. 57, No. 6. pp. 662-669.
@article{b00b72f11bad4d578ccf37589c5ce9cc,
title = "The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: A population study",
abstract = "We compared omeprazole and mephenytoin as probes for the CYP2C19 metabolic polymorphism. Single oral doses of omeprazole (20 mg) or mephenytoin (100 mg) were administered at least 1 week apart to 167 healthy volunteers. Mephenytoin metabolism was measured using the amount of 4′-hydroxymephenytoin and the S R ratio of mephenytoin in an 8-hour urine collection. Omeprazole hydroxylation was measured using the ratio of omeprazole to 5′-hydroxyomeprazole in serum 2 hours after dosing. All three methods separated poor- or extensive-metabolizer phenotypes with complete concordance. Omeprazole hydroxylation correlated with the S R ratio of mephenytoin in extensive metabolizers (r2 = 0.681; p <0.001). Genotyping tests showed that six poor metabolizers of omeprazole were homozygous for a single base pair mutation in exon 5 of CYP2C19. These results support the hypothesis that omeprazole 5′-hydroxylation cosegregates with the CYP2C19 metabolic polymorphism.",
author = "Balian, {John D.} and Nadia Sukhova and Harris, {James W.} and Jan Hewett and Linda Pickle and Goldstein, {Joyce A.} and Woosley, {Raymond L.} and Flockhart, {David A.}",
year = "1995",
month = "6",
language = "English (US)",
volume = "57",
pages = "662--669",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - The hydroxylation of omeprazole correlates with S-mephenytoin metabolism

T2 - A population study

AU - Balian, John D.

AU - Sukhova, Nadia

AU - Harris, James W.

AU - Hewett, Jan

AU - Pickle, Linda

AU - Goldstein, Joyce A.

AU - Woosley, Raymond L.

AU - Flockhart, David A.

PY - 1995/6

Y1 - 1995/6

N2 - We compared omeprazole and mephenytoin as probes for the CYP2C19 metabolic polymorphism. Single oral doses of omeprazole (20 mg) or mephenytoin (100 mg) were administered at least 1 week apart to 167 healthy volunteers. Mephenytoin metabolism was measured using the amount of 4′-hydroxymephenytoin and the S R ratio of mephenytoin in an 8-hour urine collection. Omeprazole hydroxylation was measured using the ratio of omeprazole to 5′-hydroxyomeprazole in serum 2 hours after dosing. All three methods separated poor- or extensive-metabolizer phenotypes with complete concordance. Omeprazole hydroxylation correlated with the S R ratio of mephenytoin in extensive metabolizers (r2 = 0.681; p <0.001). Genotyping tests showed that six poor metabolizers of omeprazole were homozygous for a single base pair mutation in exon 5 of CYP2C19. These results support the hypothesis that omeprazole 5′-hydroxylation cosegregates with the CYP2C19 metabolic polymorphism.

AB - We compared omeprazole and mephenytoin as probes for the CYP2C19 metabolic polymorphism. Single oral doses of omeprazole (20 mg) or mephenytoin (100 mg) were administered at least 1 week apart to 167 healthy volunteers. Mephenytoin metabolism was measured using the amount of 4′-hydroxymephenytoin and the S R ratio of mephenytoin in an 8-hour urine collection. Omeprazole hydroxylation was measured using the ratio of omeprazole to 5′-hydroxyomeprazole in serum 2 hours after dosing. All three methods separated poor- or extensive-metabolizer phenotypes with complete concordance. Omeprazole hydroxylation correlated with the S R ratio of mephenytoin in extensive metabolizers (r2 = 0.681; p <0.001). Genotyping tests showed that six poor metabolizers of omeprazole were homozygous for a single base pair mutation in exon 5 of CYP2C19. These results support the hypothesis that omeprazole 5′-hydroxylation cosegregates with the CYP2C19 metabolic polymorphism.

UR - http://www.scopus.com/inward/record.url?scp=0029018767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029018767&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 662

EP - 669

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -